EUVIMEDEUVIMED entdecken
Crossref

Development of an Interactive Tool to Support Shared Decision‐Making in Rheumatoid Arthritis: Treatment Attribute Preference

Jeffrey R Curtis iD, Kerri Ford, Stefano Fiore, Ted R Mikuls iD, Kevin Shaney, Vaneet Sethi

Arthritis Care & Research · 2024-02 · 76 (2) · 181-190

DOI: 10.1002/acr.25223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis Care & Research, online erschienen am 13.11.2023. Verfasst von Jeffrey R Curtis und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Alabama at Birmingham, Birmingham, Alabama. Hauptthemen laut MEDLINE: Decision Making, Shared, Arthritis, Rheumatoid. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Sanofi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

An interactive tool identifying treatment attributes important to patients can enhance shared decision‐making (SDM) in rheumatoid arthritis (RA). A formative survey was conducted to identify the most important treatment attributes from patients’ perspective, which can be used to develop an interactive SDM tool.

Methods

The survey was performed in two phases: qualitative interviews and quantitative surveys. The qualitative interviews were conducted to inform the design of the quantitative survey. In qualitative interviews, patients with RA (n = 10) and rheumatologists (n = 10) were introduced to the SDM tool concept. Feedback on the design and scope of the SDM tool was used to develop a quantitative survey, conducted in a large sample size of patients. Patient preferences for treatment attributes (route of administration and dosing frequency, serious side effects, out‐of‐pocket costs, efficacy, and monitoring requirement) were assessed via adaptive conjoint exercise involving ranking of hypothetical RA treatment configurations.

Results

A total of 944 patients (males: 43%, females: 57%) with RA participated in the quantitative survey. Route of administration and dosing frequency (38%) followed by serious side effects (33%) were the two most important treatment attributes for individual patients. The recontact survey (n = 172/944) estimated tool stability of 72% (n = 124/172) in terms of the relative importance of treatment attributes.

Conclusion

The findings of this survey could be used in the development of an SDM tool that can potentially provide insights into patient preferences and is generally well received by patients and rheumatologists with good agreement and reliability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Decision Making, SharedArthritis, RheumatoidMaleFemaleHumansReproducibility of ResultsRheumatologistsPatient Preference

Autor:innen und Institutionen

  • University of Alabama at Birmingham, Birmingham, Alabama.
  • Sanofi, Cambridge, Massachusetts.
  • Sanofi, Bridgewater, New Jersey.
  • University of Nebraska Medical Center and VA Nebraska-Western Iowa Health Care System, Omaha, Nebraska.
  • ZS Associates, Princeton, New Jersey.
  • ZS Associates, Chicago, Illinois.

ORCID-Profile: Jeffrey R Curtis, Ted R Mikuls

Förderung

  • Sanofi

Zitieren

APA

Curtis, J. R., Ford, K., Fiore, S., Mikuls, T. R., Shaney, K., & Sethi, V. (2024). Development of an Interactive Tool to Support Shared Decision‐Making in Rheumatoid Arthritis: Treatment Attribute Preference. Arthritis Care & Research, 76(2), 181-190. https://doi.org/10.1002/acr.25223

Vancouver

Curtis JR, Ford K, Fiore S, Mikuls TR, Shaney K, Sethi V. Development of an Interactive Tool to Support Shared Decision‐Making in Rheumatoid Arthritis: Treatment Attribute Preference. Arthritis Care & Research. 2024;76(2):181-190. doi:10.1002/acr.25223

BibTeX
@article{Curtis2024,
  author = {Curtis, Jeffrey R and Ford, Kerri and Fiore, Stefano and Mikuls, Ted R and Shaney, Kevin and Sethi, Vaneet},
  title = {Development of an Interactive Tool to Support Shared Decision‐Making in Rheumatoid Arthritis: Treatment Attribute Preference},
  journal = {Arthritis Care & Research},
  year = {2024},
  volume = {76},
  number = {2},
  pages = {181--190},
  doi = {10.1002/acr.25223}
}
Kostenlos starten →